Press release
Advanced Therapeutics Pharmaceutical Outsourcing Market Anticipated To Witness Robust Growth, Surpassing $10.27 Billion By 2029
Advanced Therapeutics Pharmaceutical Outsourcing
What Is the Current Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Its Estimated Growth Rate?
Although there has been consistent growth for the advanced therapeutics pharmaceutical outsourcing market in recent years, the market size is predicted to rise from $8.07 billion in 2024 to a staggering $8.43 billion in 2025, which reflects a compound annual growth rate (CAGR) of 4.5%. Several factors contribute to this market growth during the historical period, such as the expansion of biopharmaceutical infrastructure, regulatory compliance, an escalated requirement for novel drugs to manage chronic and fatal diseases, operational efficiency improvements, along with an increased demand for personalized medicine.
Expectations are high for the advanced therapeutics pharmaceutical outsourcing market, with projections suggesting robust growth in the near future. The market is set to expand to an impressive $10.27 billion by 2029, marking an annual compound growth rate (CAGR) of 5.1%. The surge in this forecast period is related to a rise in the application of cell and gene therapies, an increased emphasis on mRNA therapies, and a growing demand for avant-garde treatment methods. Further contributing to this growth are advantages offered by outsourcing partners, including greater efficiency and cost-saving benefits, as well as shared innovation. The forecast period is also set to see key trends such as technological progression, growing expertise in advanced therapeutics, an escalating lineup of ground-breaking therapies, the incorporation of state-of-the-art technology, and swift developments in gene therapy, cell therapy, and mRNA technologies.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13768
How Are Emerging Segments Shaping the Advanced Therapeutics Pharmaceutical Outsourcing Market Landscape?
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented -
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Cardiology, Infectious Diseases, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
Which Growth Factors Are Influencing Advanced Therapeutics Pharmaceutical Outsourcing Market Expansion?
The upward trend in the use of cell and gene therapies is projected to stimulate the growth in the market for advanced therapeutics pharmaceutical outsourcing. Cell and gene therapies stand as cutting-edge treatments that employ living cells or genetic material to combat diseases. Providers with established records and skilled personnel are accessed through advanced therapeutics pharmaceutical outsourcing, sparing firms the time and resources required to build their own teams for cell and gene therapies. For example, Nature, a scientific journal based in the UK, reported in November 2023 that the count of new patients receiving gene therapies is foreseen to rise from 16,244 in 2020 to 94,696 by 2025. As such, the escalated usage of cell and gene therapies is spurring on the growth of the market for advanced therapeutics pharmaceutical outsourcing.
Who Are the Dominant Players Across Different Advanced Therapeutics Pharmaceutical Outsourcing Market Segments?
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market report are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Croda International Plc, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, Marken, AGC Biologics, Evotec SE, ProPharma Group, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cryoport Systems Inc., Cytovance Biologics
What Are the Latest Developing Trends in the Advanced Therapeutics Pharmaceutical Outsourcing Market?
Key players in the advanced therapeutics pharmaceutical outsourcing market are focusing on strategic alliances to offer dependable services to their clients. Strategic partnerships involve a mutual venture between two or more parties, usually firms, to accomplish joint objectives that cannot be achieved independently. In a notable instance from January 2023, Lonza, a Swiss manufacturer servicing the pharmaceutical, biotechnology and nutrition industries, forged an alliance with Context Therapeutics Inc., a US-based biopharmaceutical firm developing treatments for solid tumors. The collaborative arrangement entails Lonza assessing manufacturability, constructing genes and cell lines, and developing processes for both the drug substance and product.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report
Which Geographic Regions Are Expected to Dominate the Advanced Therapeutics Pharmaceutical Outsourcing Market in the Coming Years?
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2024. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Advanced Therapeutics Pharmaceutical Outsourcing Market?
2. What is the CAGR expected in the Advanced Therapeutics Pharmaceutical Outsourcing Market?
3. What Are the Key Innovations Transforming the Advanced Therapeutics Pharmaceutical Outsourcing Industry?
4. Which Region Is Leading the Advanced Therapeutics Pharmaceutical Outsourcing Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advanced Therapeutics Pharmaceutical Outsourcing Market Anticipated To Witness Robust Growth, Surpassing $10.27 Billion By 2029 here
News-ID: 4021883 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
